SIM
LLY icon

Sentry Investment Management’s Eli Lilly LLY Stock Holding History

Sentry Investment Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,077
Closed -$2.23M – 279
2025
Q4 		$2.23M Buy
2,077
+32
+2% +$30.6K 1.47% 12
2025
Q3 		$1.73M Buy
2,045
+232
+13% +$173K 1.15% 12
2025
Q2 		$1.41M Sell
1,813
-181
-9% -$141K 0.78% 18
2025
Q1 		$1.44M Sell
1,994
-1,278
-39% -$1.06M 0.98% 16
2024
Q4 		$2.53M Sell
3,272
-49
-1% -$40.6K 1.2% 12
2024
Q3 		$2.94M Sell
3,321
-513
-13% -$461K 1.24% 11
2024
Q2 		$3.47M Sell
3,834
-785
-17% -$628K 1.54% 9
2024
Q1 		$3.59M Hold
4,619
– – 1.4% 9
2023
Q4 		$2.69M Sell
4,619
-11
-0.2% -$6.42K 1.16% 12
2023
Q3 		$2.49M Sell
4,630
-649
-12% -$334K 1.19% 12
2023
Q2 		$2.48M Sell
5,279
-286
-5% -$120K 0.94% 16
2023
Q1 		$1.91M Buy
5,565
+34
+0.6% +$11.5K 0.79% 21
2022
Q4 		$2.02M Buy
5,531
+81
+1% +$28.7K 0.89% 17
2022
Q3 		$1.76M Hold
5,450
– – 0.84% 18
2022
Q2 		$1.77M Sell
5,450
-905
-14% -$272K 0.8% 22
2022
Q1 		$1.82M Sell
6,355
-1,069
-14% -$275K 0.58% 30
2021
Q4 		$2.05M Buy
7,424
+746
+11% +$189K 0.54% 36
2021
Q3 		$1.54M Sell
6,678
-1,676
-20% -$414K 0.45% 42
2021
Q2 		$1.92M Hold
8,354
– – 0.49% 40
2021
Q1 		$1.56M Sell
8,354
-39,899
-83% -$7.8M 0.43% 49
2020
Q4 		$8.15M Sell
48,253
-3,125
-6% -$467K 0.41% 59
2020
Q3 		$7.61M Buy
51,378
+2,088
+4% +$323K 0.42% 61
2020
Q2 		$8.09M Sell
49,290
-4,288
-8% -$658K 0.49% 44
2020
Q1 		$7.43M Sell
53,578
-43
-0.1% -$5.91K 0.55% 45
2019
Q4 		$7.05M Hold
53,621
– – 0.42% 57
2019
Q3 		$6M Hold
53,621
– – 0.39% 62
2019
Q2 		$5.94M Sell
53,621
-65
-0.1% -$7.65K 0.39% 62
2019
Q1 		$6.97M Sell
53,686
-9,276
-15% -$1.13M 0.48% 49
2018
Q4 		$7.29M Sell
62,962
-1,618
-3% -$181K 0.53% 45
2018
Q3 		$6.93M Hold
64,580
– – 0.42% 58
2018
Q2 		$5.51M Sell
64,580
-6,319
-9% -$519K 0.36% 63
2018
Q1 		$5.49M Sell
70,899
-6,688
-9% -$538K 0.33% 75
2017
Q4 		$6.55M Sell
77,587
-30
-0% -$2.55K 0.36% 70
2017
Q3 		$6.64M Sell
77,617
-51
-0.1% -$4.18K 0.25% 68
2017
Q2 		$6.39M Buy
77,668
+506
+0.7% +$41.3K 0.25% 69
2017
Q1 		$6.49M Sell
77,162
-1,842
-2% -$148K 0.27% 61
2016
Q4 		$5.81M Buy
79,004
+1,477
+2% +$110K 0.24% 70
2016
Q3 		$6.22M Buy
77,527
+1,939
+3% +$155K 0.27% 60
2016
Q2 		$5.95M Hold
75,588
– – 0.26% 62
2016
Q1 		$5.44M Hold
75,588
– – 0.25% 65
2015
Q4 		$6.37M Buy
75,588
+5,193
+7% +$431K 0.29% 59
2015
Q3 		$5.89M Sell
70,395
-1,700
-2% -$144K 0.29% 67
2015
Q2 		$6.02M Buy
72,095
+2,750
+4% +$210K 0.28% 67
2015
Q1 		$5.04M Buy
69,345
+10,100
+17% +$719K 0.24% 76
2014
Q4 		$4.09M Buy
59,245
+10,435
+21% +$704K 0.2% 88
2014
Q3 		$3.17M Sell
48,810
-5,809
-11% -$368K 0.16% 102
2014
Q2 		$3.4M Sell
54,619
-4,178
-7% -$249K 0.18% 98
2014
Q1 		$3.46M Hold
58,797
– – 0.18% 86
2013
Q4 		$3M Sell
58,797
-15,675
-21% -$785K 0.16% 106
2013
Q3 		$3.75M Buy
74,472
+15,902
+27% +$833K 0.22% 73
2013
Q2 		$2.88M Buy
+58,570
New +$3.19M 0.17% 65

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sentry Investment Management's LLY Position: Q1 2026 in Review

Sentry Investment Management sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 2,077 shares — an estimated $2.23M sold.

Sentry Investment Management first reported a position in LLY in Q2 2013 and held it in 51 quarters. The position peaked at $8.15M in Q4 2020. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Sentry Investment Management reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Sentry Investment Management sold 2,077 Eli Lilly shares in Q1 2026, an estimated $2.23M.
  • Sentry Investment Management first reported a position in Eli Lilly in Q2 2013 and held it in 51 quarters.
  • Sentry Investment Management's Eli Lilly position peaked at $8.15M in Q4 2020.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Sentry Investment Management's 13F filing for Q1 2026, filed 8 May 2026.